Transplant-associated Thrombotic Microangiopathy
📧 Sign up to get email alerts when something new happens for Transplant-associated Thrombotic Microangiopathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Assessing the Incidence of Transplant Associated Thrombotic Microangiopathy (TA-TMA) in Adult Patients Undergoing Allogeneic Stem Cell Transplant (SCT)
A clinical trial is evaluating how frequently transplant-associated thrombotic microangiopathy occurs in adults undergoing allogeneic stem c…
-
CLINICAL_TRIALS research · 2025-12-12Clinical Trial Update: N-Acetylcysteine as Therapy for Transplantation- Associated Thrombotic Microangiopathy [Phase 2, Phase 3]
Clinical trial update for N-Acetylcysteine as therapy for transplant-associated thrombotic microangiopathy, a Phase 2/Phase 3 study sponsore…
-
CLINICAL_TRIALS trial_result · 2025-11-28Clinical Trial Update: A Study of Pegcetacoplan for Patients With Transplant-associated Thrombotic Microangiopathy After Hematopoietic Stem Cell Transplantation [Phase 2]
Phase 2 study of Pegcetacoplan for transplant-associated thrombotic microangiopathy after hematopoietic stem cell transplantation completed;…
-
CLINICAL_TRIALS research · 2025-08-06Clinical Trial Update: Identification of Plasma Biomarkers for Early Diagnosis of Transplant-associated Thrombotic Microangiopathy
This recruiting clinical study aims to identify plasma biomarkers for early diagnosis of transplant-associated thrombotic microangiopathy in…
-
CLINICAL_TRIALS trial_result · 2025-05-15Clinical Trial Update: Nomacopan (rVA576) in Transplant Associated Thrombotic Microangiopathy [Phase 3]
Phase 3 trial of Nomacopan for transplant-associated thrombotic microangiopathy was terminated, with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2024-08-07Clinical Trial Update: Defibrotide Prophylaxis of Transplant Associated-Thrombotic Microangiopathy for Neuroblastoma [Phase 2]
A Phase 2 trial evaluating defibrotide prophylaxis to prevent transplant-associated thrombotic microangiopathy in neuroblastoma patients has…